{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:40:10Z","timestamp":1792784410200,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Disease","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272200900035C"],"award-info":[{"award-number":["HHSN272200900035C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201323C"],"award-info":[{"award-number":["HHSN272201323C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Public Health Service","award":["R01AI104002"],"award-info":[{"award-number":["R01AI104002"]}]},{"name":"Public Health Service","award":["U19AI083019"],"award-info":[{"award-number":["U19AI083019"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.vaccine.2017.01.053","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T04:31:12Z","timestamp":1488861072000},"page":"1964-1971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response"],"prefix":"10.1016","volume":"35","author":[{"given":"Peter","family":"Probst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B.","family":"Grigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myra","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueh-Ming","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee C.","family":"Ireton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Michael","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn P.","family":"Iadonato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin M.","family":"Bedard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.01.053_b0005","unstructured":"World Health Organization. Influenza fact sheet; 2016. http:\/\/www.who.int\/mediacentre\/factsheets\/fs211\/en\/ [accessed December 21, 2016]."},{"key":"10.1016\/j.vaccine.2017.01.053_b0010","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1750-2659.2009.00073.x","article-title":"Estimates of US influenza-associated deaths made using four different methods","volume":"3","author":"Thompson","year":"2009","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2017.01.053_b0015","first-page":"151","article-title":"Inactivated and adjuvanted influenza vaccines","volume":"386","author":"Del Giudice","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2017.01.053_b0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2017.01.053_b0025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2015.02.017","article-title":"RIG-I in RNA virus recognition","volume":"479\u2013480","author":"Kell","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.01.053_b0030","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.immuni.2011.05.003","article-title":"Immune signaling by RIG-I-like receptors","volume":"34","author":"Loo","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2017.01.053_b0035","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12250-015-3604-5","article-title":"Emerging complexity and new roles for the RIG-I-like receptors in innate antiviral immunity","volume":"30","author":"Errett","year":"2015","journal-title":"Virol Sin"},{"key":"10.1016\/j.vaccine.2017.01.053_b0040","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/JVI.02338-12","article-title":"A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant","volume":"87","author":"Mart\u00ednez-Gil","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.01.053_b0045","doi-asserted-by":"crossref","first-page":"13990","DOI":"10.1128\/JVI.02273-14","article-title":"Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity","volume":"88","author":"Kulkarni","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.01.053_b0050","doi-asserted-by":"crossref","first-page":"7334","DOI":"10.1128\/JVI.06867-11","article-title":"Isoflavone agonists of IRF-3 dependent signaling have antiviral activity against RNA viruses","volume":"86","author":"Bedard","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.01.053_b0055","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/JVI.79.5.2689-2699.2005","article-title":"Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I","volume":"79","author":"Sumpter","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.01.053_b0060","unstructured":"World Health Organization. WHO manual on animal influenza diagnosis and surveillance. http:\/\/www.who.int\/csr\/resources\/publications\/influenza\/en\/whocdscsrncs20025rev.pdf [accessed December 21, 2016]."},{"key":"10.1016\/j.vaccine.2017.01.053_b0065","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1128\/JCM.00229-11","article-title":"Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations","volume":"49","author":"Veguilla","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.01.053_b0070","unstructured":"FDA. Guidance for industry: clinical data needed to support the licensure of seasonal inactivated influenza vaccines; 2014."},{"key":"10.1016\/j.vaccine.2017.01.053_b0075","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1517\/17460441.2012.699958","article-title":"Systematic identification of small molecule adjuvants","volume":"7","author":"Flower","year":"2012","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.vaccine.2017.01.053_b0080","doi-asserted-by":"crossref","first-page":"263ra160","DOI":"10.1126\/scitranslmed.3009980","article-title":"Rational design of small molecules as vaccine adjuvants","volume":"6","author":"Wu","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2017.01.053_b0085","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1128\/JVI.01250-10","article-title":"Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine","volume":"85","author":"Luke","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.01.053_b0090","doi-asserted-by":"crossref","first-page":"e60038","DOI":"10.1371\/journal.pone.0060038","article-title":"The chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant","volume":"8","author":"Tang","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2017.01.053_b0095","doi-asserted-by":"crossref","first-page":"13105","DOI":"10.1128\/JVI.01544-07","article-title":"Virally delivered cytokines alter the immune response to future lung infections","volume":"81","author":"Harker","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.01.053_b0100","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1365-2222.2007.02767.x","article-title":"Intranasal delivery of whole influenza vaccine prevents subsequent allergen-induced sensitization and airway hyper-reactivity in mice","volume":"37","author":"Minne","year":"2007","journal-title":"Clin Exp Allergy J Br Soc Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2017.01.053_b0105","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1111\/irv.12124","article-title":"Intranasal influenza vaccination using a new synthetic mucosal adjuvant SF-10: induction of potent local and systemic immunity with balanced Th1 and Th2 responses","volume":"7","author":"Kimoto","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2017.01.053_b0110","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1126\/science.1221064","article-title":"New paradigms in type 2 immunity","volume":"337","author":"Pulendran","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2017.01.053_b0115","doi-asserted-by":"crossref","first-page":"e1002003","DOI":"10.1371\/journal.ppat.1002003","article-title":"Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens","volume":"7","author":"Allen","year":"2011","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301184?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301184?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T15:58:39Z","timestamp":1535990319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17301184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":23,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0264410X17301184"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.053","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}